As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.

H.E.L.P. ApheresisNegative

AI Analysis

Summary

New research shows Long Covid affects 1 in 6 US patients, doubling prior estimates. Insurance denials and scarcity of domestic apheresis providers are driving US patients to seek H.E.L.P. Apheresis treatment abroad.

Importance:2/10

Sentiment:

-0.30

Long CovidApheresisInsurancePatient AccessInternational Treatment

Related Companies

$ISCO

Read the original article

Published by GlobeNewswire Clinical Studies on July 29, 2026 5:30 PM

Read Original